HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas G Tilley Selected Research

Fibrosis (Cirrhosis)

11/2023Loss of Myeloid Cell-Specific β2-Adrenergic Receptor Expression Ameliorates Cardiac Function and Remodeling after Acute Ischemia.
1/2020Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload.
1/2020Leukocyte-Dependent Regulation of Cardiac Fibrosis.
2/2015Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas G Tilley Research Topics

Disease

20Heart Failure
01/2023 - 05/2006
10Cardiomegaly (Heart Hypertrophy)
10/2023 - 01/2013
6Hypertrophy
01/2022 - 05/2006
6Cardiovascular Diseases (Cardiovascular Disease)
10/2018 - 04/2002
5Myocardial Infarction
10/2023 - 01/2014
5Inflammation (Inflammations)
03/2020 - 04/2015
4Fibrosis (Cirrhosis)
11/2023 - 02/2015
4Cardiomyopathies (Cardiomyopathy)
10/2018 - 11/2014
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2018 - 11/2014
2Neoplasms (Cancer)
01/2022 - 11/2016
2Ischemia
01/2020 - 01/2018
2Hypoxia (Hypoxemia)
01/2018 - 08/2013
2Hyperlipidemias (Hyperlipidemia)
01/2016 - 04/2015
2Hypertension (High Blood Pressure)
06/2015 - 06/2011
2Heart Diseases (Heart Disease)
03/2009 - 11/2008
1Hypothyroidism
10/2023
1Heart Rupture
01/2020
1Weight Gain
12/2019
1Contusions
12/2019
1Atrophy
12/2019
1Cardiac Arrhythmias (Arrythmia)
10/2019
1Edema (Dropsy)
10/2019
1Myocarditis (Carditis)
10/2018
1Infarction (Infarctions)
01/2018
1Diabetic Cardiomyopathies
01/2018
1Reperfusion Injury
01/2017
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2017
1Acquired Immunodeficiency Syndrome (AIDS)
08/2015
1Pain (Aches)
08/2015
1Vascular Remodeling
06/2015
1Atherosclerosis
04/2015
1Bradycardia
05/2014
1Hypovolemia
08/2013

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2023 - 11/2014
5Adrenergic Receptors (Adrenergic Receptor)IBA
01/2023 - 01/2014
5G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2018 - 07/2011
4ErbB Receptors (EGF Receptor)IBA
01/2022 - 05/2013
3LigandsIBA
08/2015 - 11/2008
2Small Interfering RNA (siRNA)IBA
11/2023 - 03/2016
2salicylhydroxamic acid (SHAM)IBA
10/2023 - 01/2020
2Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2022 - 02/2015
2Caspase 1 (ICE Protease)IBA
01/2016 - 04/2015
2beta Adrenergic ReceptorsIBA
10/2015 - 05/2006
2transcription factor NF-AT c3IBA
10/2015 - 12/2014
2Arginine Vasopressin (Argipressin)IBA
11/2014 - 08/2013
2beta-ArrestinsIBA
03/2009 - 11/2008
2GTP-Binding Proteins (G-Protein)IBA
03/2009 - 11/2008
1Interleukin-10 (Interleukin 10)IBA
10/2023
1G-Protein-Coupled Receptor Kinase 5IBA
01/2022
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
01/2022
1NucleotidesIBA
03/2020
1Factor X (Stuart Factor)IBA
01/2020
1RivaroxabanIBA
01/2020
1nicotinamide-beta-ribosideIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1protease-activated receptor 4IBA
01/2020
1Mitochondrial DNA (mtDNA)IBA
12/2019
1Formoterol Fumarate (Oxis)FDA Link
12/2019
1Tolterodine Tartrate (Detrol)FDA Link
10/2019
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2019
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2019
1Protein Isoforms (Isoforms)IBA
01/2019
1G-Protein-Coupled Receptor KinasesIBA
10/2018
1DNA (Deoxyribonucleic Acid)IBA
10/2018
1Superoxides (Superoxide)IBA
01/2018
1Paroxetine (Paxil)FDA LinkGeneric
10/2017
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
10/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
07/2017
1Cathepsin GIBA
01/2017
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2017
1Peptide Hydrolases (Proteases)FDA Link
01/2017
1Chymases (Chymase)IBA
01/2017
1CatecholaminesIBA
12/2016
1Vasopressins (Vasopressin)IBA
11/2016
1ClenbuterolIBA
10/2016
1G-Protein-Coupled Receptor Kinase 2IBA
10/2016
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
03/2016
1Orphan Nuclear ReceptorsIBA
10/2015
1RNA (Ribonucleic Acid)IBA
08/2015
1lysophosphatidylinositolIBA
08/2015
1Angiotensin IIIBA
06/2015
1DisintegrinsIBA
06/2015
1Metalloproteases (Metalloproteinases)IBA
06/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2015
14-phenylbutyric acid (Buphenyl)FDA Link
06/2015
1Apolipoproteins E (ApoE)IBA
04/2015
1CytokinesIBA
04/2015
1urotensin IIIBA
05/2014
1Cholinergic Agents (Cholinergics)IBA
05/2014
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2014
1Caspase 3 (Caspase-3)IBA
08/2013
1Phosphotransferases (Kinase)IBA
01/2013

Therapy/Procedure

8Therapeutics
01/2022 - 03/2009
1Transplantation
11/2023
1Thrombolytic Therapy
01/2020
1Injections
01/2018
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2016
1Highly Active Antiretroviral Therapy (HAART)
08/2015
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2015
1Aftercare (After-Treatment)
08/2013